TOFO Insulin Combination Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 211 participants.
Also called NCT02201004
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 211 participants
- Sponsor
- Registry
-
NCT02201004
-
- Other papers using this trial's data
- Efficacy and safety of tofogliflozin in Japanese patients with type 2 diabetes mellitus with inadequate glycaemic control on insulin therapy (J-STEP/INS): Results of a 16-week randomized, double-blind, placebo-controlled multicentre trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT02201004. Randomized; double masking; primary purpose treatment. Start 2014-06 (registry gives no type); primary completion 2016-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- TOFO Insulin Combination Trial
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- TOFOGLIFLOZIN CSG452
- Intervention (Drug)
- insulin
- Intervention (Drug)
- placebo
- Lead sponsor
- Sanofi
- Collaborator
- Kowa Company, Ltd.
Record details
- Record id
cardio:ct-nct02201004- Content hash
be6d37bb8ec116ae2d7fbb07a93c2a466123031a60c5fe73a13323d5cc3d63e3